CD8A and melanoma: Further analysis revealed that some of these CD8+ TILs were targeting endogenous melanoma-associated antigens TRP-2 and gp100 (Figs E and F in S3 Fig), suggesting repertoire expansion following adoptive T-cell transfer [34,35].